Effect of vitamin D supplementation on control of gestational diabetes

Study of the effect of vitamin D oral supplementation on glycemic control, serum levels of growth hormone, insulin-like growth factor-1 and lipid profile in gestational diabetes mellitus patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130616013678N29

Enrollment

Registered

2019-03-26

Start date

2018-08-11

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus. Diabetes Mellitus in pregnancy

Interventions

Intervention 1: Intervention group: The Intervention group will receive a Vitamin D3 2000 IU supplement daily for the period of 6 weeks. Intervention 2: Control group: The control group will receive a

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Detection of gestational diabetes between 24-28 weeks of pregnancy Tend to participate in the study Age category between 18-40 years old Consumption of daily multivitamins

Exclusion criteria

Exclusion criteria: Twin or multiple pregnancy Having a body mass index greater than 40 Consumption of Vitamin D supplementation at least three months before the intervention Consumption of Insulin or Metformin People with cardiovascular diseases, digestive disorders, hypertension, inflammatory diseases and hypothyroidism Using cigarette and alcohol due to the effect on insulin metabolism and lipid profile

Design outcomes

Primary

Measure	Time frame
25 Hydroxy Vitamin D3. Timepoint: Before and 6 weeks after trials. Method of measurement: ElectroChemi Luminescence method.;Fasting Blood Sugar. Timepoint: Before and 6 weeks after trials. Method of measurement: Enzymatic method.;Serum Insulin. Timepoint: Before and 6 weeks after trials. Method of measurement: ELISA method.;Total Cholesterol. Timepoint: Before and 6 weeks after trials. Method of measurement: Enzymatic method.;Triglyceride. Timepoint: Before and 6 weeks after trials. Method of measurement: Enzymatic method.;LDL Cholesterol. Timepoint: Before and 6 weeks after trials. Method of measurement: Enzymatic method.;HDL Cholesterol. Timepoint: Before and 6 weeks after trials. Method of measurement: Enzymatic method.;Growth Hormone. Timepoint: Before and 6 weeks after trials. Method of measurement: ELISA method.;Insulin Like Growth Factor-1. Timepoint: Before and 6 weeks after trials. Method of measurement: ELISA method.	—

Measure

Time frame

25 Hydroxy Vitamin D3. Timepoint: Before and 6 weeks after trials. Method of measurement: ElectroChemi Luminescence method.;Fasting Blood Sugar. Timepoint: Before and 6 weeks after trials. Method of measurement: Enzymatic method.;Serum Insulin. Timepoint: Before and 6 weeks after trials. Method of measurement: ELISA method.;Total Cholesterol. Timepoint: Before and 6 weeks after trials. Method of measurement: Enzymatic method.;Triglyceride. Timepoint: Before and 6 weeks after trials. Method of measurement: Enzymatic method.;LDL Cholesterol. Timepoint: Before and 6 weeks after trials. Method of measurement: Enzymatic method.;HDL Cholesterol. Timepoint: Before and 6 weeks after trials. Method of measurement: Enzymatic method.;Growth Hormone. Timepoint: Before and 6 weeks after trials. Method of measurement: ELISA method.;Insulin Like Growth Factor-1. Timepoint: Before and 6 weeks after trials. Method of measurement: ELISA method.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Saeid Ghavamzadeh

Oroumia University of Medical Sciences

Ghavamzadeh_s@yahoo.com+98 44 3278 0803

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026